Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease

Arthritis Research & Therapy · Published 2026-04-14 · DOI 10.1186/s13075-026-03803-z

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1186/s13075-026-03803-z

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Related articles